Table 5.
Genes | Sig. | M Veh | M Cort | F Veh | F Cort |
---|---|---|---|---|---|
GR, MR, and GR target genes | |||||
Nr3c1 | — | 1.00 ± 0.17 | 0.90 ± 0.06 | 0.88 ± 0.20 | 0.91 ± 0.15 |
Fkbp5 | S,C,× | 1.00 ± 0.10 | 18.11 ± 1.06a | 0.69 ± 0.13 | 12.49 ± 2.29a,b |
Tsc22d3 | C | 1.00 ± 0.20 | 3.99 ± 0.67a | 1.07 ± 0.21 | 4.30 ± 0.95a |
Nr3c2 | — | 1.00 ± 0.10 | 1.36 ± 0.29 | 1.22 ± 0.34 | 1.21 ± 0.13 |
Muscle atrophy | |||||
Foxo1 | C | 1.00 ± 0.13 | 12.80 ± 2.11a | 1.30 ± 0.30 | 14.25 ± 3.46a |
Klf15 | C | 1.00 ± 0.18 | 2.70 ± 0.63a | 1.22 ± 0.24 | 2.23 ± 0.36 |
Glucose transport | |||||
Irs1 | S,C,× | 1.00 ± 0.17 | 0.66 ± 0.10 | 2.24 ± 0.45b | 0.61 ± 0.19a |
Slc2a1 | — | 1.00 ± 0.27 | 1.60 ± 0.61 | 1.08 ± 0.13 | 0.81 ± 0.26 |
Slc2a4 | — | 1.00 ± 0.08 | 1.04 ± 0.09 | 1.01 ± 0.16 | 1.24 ± 0.12 |
Chrebpb | C | 1.00 ± 0.35 | 13.06 ± 1.22a | 0.80 ± 0.06 | 18.04 ± 10.57a |
Gene expression was normalized to Gapdh and Rn18s expression and expressed relative to the vehicle-treated male mice. Sig. indicates significant effects (P < 0.05) analyzed with two-way ANOVA.
Abbreviations: C, corticosterone treatment; S, sex; ×, interaction of corticosterone treatment and sex.
P < 0.05, for effect of corticosterone treatment in mice of the same sex, by post hoc test.
P < 0.05, for sex difference between mice with the same treatment, by post hoc test.